- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 243/26 - Preparation from compounds already containing the benzodiazepine skeleton
Patent holdings for IPC class C07D 243/26
Total number of patents in this class: 34
10-year publication summary
|
1
|
3
|
2
|
3
|
4
|
0
|
6
|
1
|
1
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4757 |
9 |
| ImmunoGen, Inc. | 376 |
6 |
| Immunome Inc. | 71 |
3 |
| Trio Medicines Limited | 13 |
3 |
| F. Hoffmann-La Roche AG | 7808 |
2 |
| Enanta Pharmaceuticals, Inc. | 424 |
2 |
| University of Durham | 120 |
2 |
| Ayala Pharmaceuticals Inc. | 11 |
2 |
| Hoffmann-La Roche Inc. | 3818 |
1 |
| Arrow Therapeutics Limited | 8 |
1 |
| Matrix Laboratories Limited | 85 |
1 |
| Wavelength Enterprises Ltd | 5 |
1 |
| Immunome, Inc. | 1 |
1 |
| Other owners | 0 |